期刊文献+

视黄醇结合蛋白的检测方法及临床应用 被引量:1

The Detection Method and Clinical Application of Retinol Binding Protein
下载PDF
导出
摘要 视黄醇结合蛋白是人体血液中的转运蛋白,以视黄醇和蛋白结合的形式存在,一旦复合物中的视黄醇和靶细胞结合,极有可能导致视黄醇结合蛋白和蛋白分离,由肾小球滤出或肾小管细胞吸收。近年研究显示,视黄醇结合蛋白水平能真实、敏感的反映肝功能、肾小管功能损伤度,是反映营养状况、肾脏状况和疾病发展及转归的重要指标。当前,临床检测视黄醇结合蛋白的方法比较多,如放射免疫分析、免疫比浊、免疫电泳、酶联免疫吸附法等,其中,免疫比浊法对肝病、肾病早期诊断具有重大意义,具有操作简便、灵敏度高、实用性强的优势。下面,本文从视黄醇结合蛋白的检测方法出发,总结视黄醇结合蛋白的临床应用。 Retinol-binding protein is a transport protein in human blood, it exists in the form of retinol and protein binding. Once retinol in the complex binds to target cells, it is very likely to cause the separation of retinol-binding protein and protein. By glomerular filtration or tubular cell absorption. Recent studies have shown that retinol-binding protein levels can truly and sensitively reflect liver function and renal tubular injury, and are important indicators of nutritional status, kidney status, and disease development and prognosis. At present, there are many methods for clinical detection of retinol-binding proteins, such as radioimmunoassay, immunoturbidimetry, immunoelectrophoresis, and enzyme-linked immunosorbent assay. Among them, immunoturbidimetric assay is of great significance in the early diagnosis of liver diseases and nephropathy. Simple operation, high sensitivity and strong practicality. In the following, this article starts with the detection method of retinol binding protein and summarizes the clinical application of retinol binding protein.
作者 杜小华 DU Xiaohua(Department of Clinical Laboratory, Kangan Hospital (Primary Infectious Disease Hospital), Mudanjiang City, Heilongjiang Province, Mudanjiang Heilongjiang 157000, China)
出处 《中国卫生标准管理》 2018年第10期109-111,共3页 China Health Standard Management
关键词 视黄醇结合蛋白 检测方法 临床应用 retinol binding protein detection method clinical application
  • 相关文献

参考文献8

二级参考文献83

  • 1林维平,李思光,徐琪寿.视黄醇结合蛋白的分子机制及临床应用[J].军事医学科学院院刊,2005,29(5):492-495. 被引量:24
  • 2Ndrepepa G,Kastrati A,Braun S,et al.Circulating homocysteine levels in patients with type 2 diabetes mellitus[J].Nutr Metab Cardiovasc Dis,2008,18(1):66-73.
  • 3Li ZZ,Lu XZ,Liu JB,et al.Serum retinol-binding protein 4 levels in patients with diabetic retinopathy[J].J Int Med Res,2010,38(1):95-99.
  • 4Ellis D,Forrest KY,Erbey F,et al.Urinary measurement of transforming growth factor-beta and type Ⅳ collagen as new markers of renalinjury:application in diabetic nephropathy[J].Clin Chem,2010,44(5):950-956.
  • 5Ozken Y,Ozkan E,Simsek B.Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease[J].Int J Cardiol,2002,82(3):269-277.
  • 6Xu QF,Ji QH.Research on early diagnosis in diabetic nephropathy[J].Shaanxi Medical Journal,2010,39(7):880-883.
  • 7Niskanen LK,Laaksonen DN,Nyyssonen K,et al.Uric acid level as a risk factor for cardiovascular and all cause mortality in middle-aged men:a prospective cohort study[J].Arch Int Med,2004,164(14);1546-1551.
  • 8赖子飞.尿视黄醇结合蛋白在肾脏病中的检测及评价[J].海南医药,2011,22(23):34-35.
  • 9耿爽,叶俊杰.糖尿病视网膜病变发病机制及其药物治疗研究进展[J].中华眼科杂志,2008,44(1):76-81. 被引量:10
  • 10Christou GA, Tselepis AD, Kiortsis DN. The metabolic role of retinol binding protein 4: an update[ J]. Horm Metab Res,2012, 44(1) :6-14. DOI: 10. 1055/s-0031-1295491.

共引文献48

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部